The Big Beautiful Bill – key takeaways for alternatives funds
Lev Shoykhet, Head of Tax, Citco Fund Services (USA) Inc., analyses the impact of the “One Big Beautiful Bill Act” and what it means for the taxation of alternatives funds, investors and portfolio companies.
The “One Big Beautiful Bill Act” (H.R. 1 (OBBA)) was signed into law on July 4th and includes several significant US tax law changes that will have implications for funds, investors, and portfolio companies. Two key takeaways are that the OBBA did not make changes to the current tax rules addressing carried interests, or to the pass-through entity tax (PTET).
Below are the highlights from the OBBA that the Citco group of companies’ (Citco) clients in the alternative investment space need to know.
- Section 899, which would have imposed additional US taxes on foreign investors and entities from “unfair” tax jurisdictions, was not included.
- The Treasury Secretary noted that this was no longer needed due to agreements reached with G7 countries but also stated that if these agreements were not implemented in a timely fashion, 899 could be revisited through the reconciliation process.
- Immediate expensing is reinstated for US R&D costs. Foreign R&D costs must still be amortized over 15 years.
- All taxpayers that incurred domestic R&D expenses after December 31, 2021, and before January 1, 2025, are permitted to elect to accelerate the remaining deductions for such expenditures over a one- or two-year period. Foreign R&D is unchanged and must continue to be capitalized over a 15-year period. The provision also includes rules to coordinate the immediate deductibility of domestic R&D expenses with the research credit.
- Permanently reinstates the EBITDA limitation for the calculation of the deduction after December 31, 2024.
- Contains a new ordering rule whereby the Section 163(j) limitation is calculated prior to any interest capitalization rule. Also, interest capitalized under Section 263(g) or 263A(f) is not business interest under Section 163(j). However, the business interest allowed under Section 163(j) is applied first to the capitalized interest and then to deducted interest. Finally, excludes subpart F and GILTI, along with any associated gross-up under Section 78, from adjusted taxable income for purposes of Section 163(j).
Section 1202 gain exclusions expanded:
- Partial exclusions available for 3- and 4-year holding periods.
- Full exclusion remains at 5 years.
- Exclusion cap increased from $10 million to $15 million.
- Gross asset cap raised from $50 million to $75 million to qualify as a QSB.
- Section 899, which would have imposed additional US taxes on foreign investors and entities from “unfair” tax jurisdictions, was not included.
- The Treasury Secretary noted that this was no longer needed due to agreements reached with G7 countries but also stated that if these agreements were not implemented in a timely fashion, 899 could be revisited through the reconciliation process.
- Immediate expensing is reinstated for US R&D costs. Foreign R&D costs must still be amortized over 15 years.
- All taxpayers that incurred domestic R&D expenses after December 31, 2021, and before January 1, 2025, are permitted to elect to accelerate the remaining deductions for such expenditures over a one- or two-year period. Foreign R&D is unchanged and must continue to be capitalized over a 15-year period. The provision also includes rules to coordinate the immediate deductibility of domestic R&D expenses with the research credit.
- Permanently reinstates the EBITDA limitation for the calculation of the deduction after December 31, 2024.
- Contains a new ordering rule whereby the Section 163(j) limitation is calculated prior to any interest capitalization rule. Also, interest capitalized under Section 263(g) or 263A(f) is not business interest under Section 163(j). However, the business interest allowed under Section 163(j) is applied first to the capitalized interest and then to deducted interest. Finally, excludes subpart F and GILTI, along with any associated gross-up under Section 78, from adjusted taxable income for purposes of Section 163(j).
Section 1202 gain exclusions expanded:
- Partial exclusions available for 3- and 4-year holding periods.
- Full exclusion remains at 5 years.
- Exclusion cap increased from $10 million to $15 million.
- Gross asset cap raised from $50 million to $75 million to qualify as a QSB.